Therapeutic cannabis extracts
OwnerJames Castilloinventor
Life of this patent
Estimating the term…
Abstract
The present invention may be one of several formulations containing cannabinoids and non-cannabinoid compounds. Cannabis plants are subjected to extraction, and the resulting extract may be supplemented with additional ingredients to achieve a desired chemical profile. Dose titration may be used to find an appropriate dose of cannabis extract to be ingested in treating medical conditions.
Claims44
A therapeutic formulation comprising a cannabis extract wherein a weight of remainder equal to at least 10% to 40% by weight of total measured cannabinoids is added.
A therapeutic formulation comprising 70% to 95% by weight of total measured cannabinoids, wherein a weight of remainder is added to the total cannabinoid weight to bring total weight up to 100% by weight.
A therapeutic formulation comprising about 20% CBD by weight, about 60% Δ8-THC by weight and about less than about 5% by weight of other cannabinoids, where the listed percentages are weight percentage.
A therapeutic formulation comprising about 24% THCA by weight, about 48% CBDA by weight
A therapeutic formulation comprising about 24% THC by weight and about 48% CBD by weight.
A therapeutic formulation comprising about 10% THCA and about 60% CBD.
A therapeutic formulation comprising:
- a cannabinoid component selected to provide less than 0.3% THC by weight
- and less than 0.3% THCA by weight, about 65-75% CBD by weight,
- and about 5-15% CBN by weight;
- at least 10% by weight remainder;
- and
- about 1-4% by weight added terpenoid compounds.
A therapeutic formulation comprising:
- a cannabinoid component selected to provide about 35% THC by weight,
- about 35% CBD by weight, about 3% CBN by weight, about 3% Δ8-THC by weight, and about 4% CBG by weight;
- at least 15% by weight remainder;
- and
- about 1-4% by weight added terpenoid compounds.
A therapeutic formulation comprising:
- a cannabinoid component selected to provide about 35% THC by weight,
- about 35% CBD by weight, about 3% CBN by weight, about 3% Δ8-THC by weight, and about 4% THCV by weight;
- at least 15% by weight remainder;
- and
- about 1-4% by weight added terpenoid compounds.
A therapeutic formulation comprising a cannabinoid component selected to provide about equal amounts by THC and CBD and less than 5% by weight each of CBN, THC, and CBG.
A therapeutic formulation comprising a cannabis component selected to provide about 24% THC by weight and about 48% CBD by weight
A therapeutic formulation comprising:
- a cannabinoid component selected to provide about 60% THC by weight, about 20% CBD by weight, about 3% CBN by weight, about 3% Δ8-THC by weight, and about 4% CBG by weight.
A therapeutic formulation comprising a cannabinoid component selected to provide about 20% CBD by weight and about 60% CBN by weight.
Dependencies are inferred from the claim text.